BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26803949)

  • 1. Analysis of colorectal cancer outcomes for the Australian National Bowel Cancer Screening Program.
    ;
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):22-32. PubMed ID: 26803949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program.
    Cole SR; Tucker GR; Osborne JM; Byrne SE; Bampton PA; Fraser RJ; Young GP
    Med J Aust; 2013 Apr; 198(6):327-30. PubMed ID: 23545032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival impact of the Australian National Bowel Cancer Screening Programme.
    Ananda S; Wong H; Faragher I; Jones IT; Steele M; Kosmider S; Desai J; Tie J; Field K; Wong R; Tran B; Bae S; Gibbs P
    Intern Med J; 2016 Feb; 46(2):166-71. PubMed ID: 26418334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.
    Lew JB; St John DJB; Xu XM; Greuter MJE; Caruana M; Cenin DR; He E; Saville M; Grogan P; Coupé VMH; Canfell K
    Lancet Public Health; 2017 Jul; 2(7):e331-e340. PubMed ID: 29253458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial impact of Australia's National Bowel Cancer Screening Program.
    Ananda SS; McLaughlin SJ; Chen F; Hayes IP; Hunter AA; Skinner IJ; Steel MC; Jones IT; Hastie IA; Rieger NA; Shedda S; Compston DJ; Gibbs P
    Med J Aust; 2009 Oct; 191(7):378-81. PubMed ID: 19807627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort.
    He E; Lew JB; Egger S; Banks E; Ward RL; Beral V; Canfell K
    Prev Med; 2018 Jan; 106():185-193. PubMed ID: 29109015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
    Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
    PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The National Bowel Cancer Screening Program: time to achieve its potential to save lives.
    Ee H; St John J
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.
    McIntosh JG; Emery JD; Wood A; Chondros P; Goodwin BC; Trevena J; Wilson C; Chang S; Hocking J; Campbell T; Macrae F; Milley K; Lew JB; Nightingale C; Dixon I; Castelli M; Lee N; Innes L; Jolley T; Fletcher S; Buchanan L; Doncovio S; Broun K; Austin G; Jiang J; Jenkins MA
    Trials; 2023 Nov; 24(1):723. PubMed ID: 37957680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening in rural and remote areas: analysis of the National Bowel Cancer Screening Program data for South Australia.
    Martini A; Javanparast S; Ward PR; Baratiny G; Gill T; Cole S; Tsourtos G; Aylward P; Jiwa M; Misan G; Wilson C; Young GP
    Rural Remote Health; 2011; 11(2):1648. PubMed ID: 21585228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History, development and future of cancer screening in Australia.
    Olver IN; Roder D
    Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
    Wood A; Emery JD; Jenkins M; Chondros P; Campbell T; Wenkart E; O'Reilly C; Cowie T; Dixon I; Toner J; Khalajzadeh H; Gutierrez JM; Govan L; Buckle G; McIntosh JG
    Trials; 2022 Jan; 23(1):31. PubMed ID: 35022080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary analysis of the cost-effectiveness of the National Bowel Cancer Screening Program: demonstrating the potential value of comprehensive real world data.
    Tran B; Keating CL; Ananda SS; Kosmider S; Jones I; Croxford M; Field KM; Carter RC; Gibbs P
    Intern Med J; 2012 Jul; 42(7):794-800. PubMed ID: 21883782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonoscopies in Australia - how much does the National Bowel Cancer Screening Program contribute to colonoscopy use?
    Worthington J; He E; Lew JB; St John J; Horn C; Grogan P; Canfell K; Feletto E
    Public Health Res Pract; 2023 Mar; 33(1):. PubMed ID: 36477980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of bowel cancer screening on the management of colorectal cancer.
    Hwang MJ; Evans T; Lawrence G; Karandikar S
    Colorectal Dis; 2014 Jun; 16(6):450-8. PubMed ID: 24617851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bowel cancer screening--a role for general practice.
    Foreman L
    Aust Fam Physician; 2009 Apr; 38(4):200-3. PubMed ID: 19350068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trust, choice and obligation: a qualitative study of enablers of colorectal cancer screening in South Australia.
    Ward PR; Coffey C; Meyer S
    Sociol Health Illn; 2015 Sep; 37(7):988-1006. PubMed ID: 25912247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology and Clinical Implications of Fecal Occult Blood Test Screen-Detected Colorectal Cancer.
    Mendis S; Hong W; Ananda S; Faragher I; Jones I; Croxford M; Steel M; Jalali A; Gard G; To YH; Lee M; Kosmider S; Wong R; Tie J; Gibbs P
    JNCI Cancer Spectr; 2022 Jan; 6(1):. PubMed ID: 35699496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening colonoscopy in Australia.
    Singh R; Mangira D; Kawano H; Matsuda T
    Dig Endosc; 2015 Apr; 27 Suppl 1():30-4. PubMed ID: 25523496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme.
    Morris EJ; Whitehouse LE; Farrell T; Nickerson C; Thomas JD; Quirke P; Rutter MD; Rees C; Finan PJ; Wilkinson JR; Patnick J
    Br J Cancer; 2012 Aug; 107(5):757-64. PubMed ID: 22850549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.